Five-Year Study: Natesto’s Impact on PSA Levels in American Males with Hypogonadism
Reading Time: 2 minutes Introduction Testosterone replacement therapy (TRT) has become a widely discussed topic among American males seeking to address symptoms of hypogonadism, such as decreased libido, fatigue, and mood disturbances. One of the newer formulations, Natesto, a nasal testosterone gel, has garnered attention for its ease of use and rapid absorption. However, the long-term effects of TRT on prostate health remain a significant concern, particularly in relation to prostate-specific antigen (PSA) levels, which are crucial indicators of prostate health. This article presents the findings of a five-year longitudinal study investigating the influence of Natesto on PSA levels in American males. Study Design...


